Ramsay Health Care
Ramsay Health Care Limited is a leading global hospital group, operating a wide range of healthcare facilities across Australia, France, and the United Kingdom. The company is renowned for providing high-quality, personalized care through its extensive network of hospitals, day surgeries, clinics, and in-home services.
Short position
Ramsay Health Care (ASX:RHC) has 5.53% of its shares on issue reported as short positions as of 5 Oct 2026, or about 12,768,017 shares. Over the past 30 days that figure has risen 0.80 percentage points, and over 90 days it has fallen 0.35 percentage points. Its highest recorded short interest was 6.04% in May 2026. RHC is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Ramsay Health Care (RHC) financials
Results, ratios and statements
Latest result
12 months to 30 Jun 2026 (TTM Jun 26) vs TTM Jun 25, figures in AUD, the reporting currency
- Revenue
- $18.46Bvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $329.2Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $1.36vs $0.10 (TTM Jun 25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +4.4%TTM
- EPS YoY
- n/mTTM
Key ratios
12 months to 30 Jun 2026 (TTM); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- 77.6%
- Operating margin
- 4.9%
- Net margin
- 1.8%
- FCF margin
- 3.8%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- 2.12×
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- 2.8×
- Cash dividends paid / net profit
- 72.3%
- Market cap
- n/a (no share count we can vouch for)
- P/E
- 40.2×
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | TTM Jun 26 | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|---|
| Revenue | $18.46B | $17.67B | $16.56B | $14.86B | $13.08B |
| Gross profit | $14.33B | $13.67B | $12.85B | $11.52B | $9.97B |
| Operating income | $897.1M | $870.5M | $833.2M | $554.2M | $230.6M |
| EBITDA | $2.01B | $1.56B | $1.81B | $1.78B | $1.61B |
| EBIT | $831.9M | $437.0M | $724.1M | $788.3M | $685.3M |
| Interest expense | $318.3M | $335.2M | $339.5M | $261.2M | $146.8M |
| Pretax income | $513.6M | $101.8M | $384.6M | $527.1M | $538.5M |
| Tax | $192.2M | $55.5M | $121.3M | $181.5M | $159.3M |
| NPAT | $329.2M | $24.0M | $888.7M | $298.1M | $274.0M |
| Net interest income | −$591.8M | −$604.4M | −$613.0M | −$474.3M | −$352.8M |
| EPS basic | $1.36 | $0.10 | $3.89 | $1.25 | $1.16 |
| EPS diluted | $1.36 | $0.10 | $3.89 | $1.25 | $1.16 |
| Shares | n/a | 230.8M | 229.8M | 229.2M | 228.9M |
Financial reports
The company's own filings, newest first
- 2026 Annual ReportAnnual Report25 Sep 2026via asx_announcements
- Preliminary Final ReportAnnual Results27 Aug 2026via asx_announcements
- Financial Results for the Year Ended 30 June 2026Financial Report27 Aug 2026via asx_announcements
- 2026 Half Year Financial ReportHalf Year Results26 Feb 2026via asx_announcements
- 2026 Half Year Results AnnouncementHalf Year Results26 Feb 2026via asx_announcements
- 2026 Half Year Results PresentationHalf Year Results26 Feb 2026via asx_announcements
- Correction to 2025 Annual ReportAnnual Report16 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report19 Sep 2025via asx_announcements
- Preliminary Final ReportAnnual Results28 Aug 2025via asx_announcements
- Financial Results for the Year Ended 30 June 2025Financial Report28 Aug 2025via asx_announcements
Showing 10 of 79 reports